Department of General Practice, Institute for Community Medicine, University Medicine Greifswald, Fleischmannstrasse 6, Greifswald, 17475, Germany.
Faculty of Applied Health Sciences, European University of Applied Sciences, Rostock, Germany.
BMC Nephrol. 2022 Jun 24;23(1):225. doi: 10.1186/s12882-022-02845-0.
Clinical practice guidelines recommend specialist referral according to different criteria. The aim was to assess recommended and observed referral rate and health care expenditure according to recommendations from: • Kidney Disease Improving Global Outcomes (KDIGO,2012) • National Institute for Health and Care Excellence (NICE,2014) • German Society of Nephrology/German Society of Internal Medicine (DGfN/DGIM,2015) • German College of General Practitioners and Family Physicians (DEGAM,2019) • Kidney failure risk equation (NICE,2021) METHODS: Data of the population-based cohort Study of Health in Pomerania were matched with claims data. Proportion of subjects meeting referral criteria and corresponding health care expenditures were calculated and projected to the population of Mecklenburg-Vorpommern.
Data from 1927 subjects were analysed. Overall proportion of subjects meeting referral criteria ranged from 4.9% (DEGAM) to 8.3% (DGfN/DGIM). The majority of patients eligible for referral were ≥ 60 years. In subjects older than 60 years, differences were even more pronounced, and rates ranged from 9.7% (DEGAM) to 16.5% (DGfN/DGIM). Estimated population level costs varied between €1,432,440 (DEGAM) and €2,386,186 (DGfN/DGIM). From 190 patients with eGFR < 60 ml/min, 15 had a risk of end stage renal disease > 5% within the next 5 years.
Applying different referral criteria results in different referral rates and costs. Referral rates exceed actually observed consultation rates. Criteria need to be evaluated in terms of available workforce, resources and regarding over- and underutilization of nephrology services.
临床实践指南根据不同标准推荐专科转诊。目的是评估根据以下建议推荐和观察到的转诊率和医疗支出:
改善全球肾脏病预后组织(KDIGO,2012 年)
英国国家卫生与临床优化研究所(NICE,2014 年)
德国肾病学会/德国内科医师学会(DGfN/DGIM,2015 年)
德国家庭医生和全科医生学院(DEGAM,2019 年)
肾功能衰竭风险方程(NICE,2021 年)
将基于人群的波罗的海健康研究的数据与索赔数据相匹配。计算符合转诊标准的受试者比例和相应的医疗支出,并将其投影到梅克伦堡-前波美拉尼亚州的人口中。
分析了 1927 名受试者的数据。符合转诊标准的受试者比例总体上从 4.9%(DEGAM)到 8.3%(DGfN/DGIM)不等。大多数符合转诊条件的患者年龄在 60 岁以上。在年龄大于 60 岁的患者中,差异更为明显,比例从 9.7%(DEGAM)到 16.5%(DGfN/DGIM)不等。估计的人口水平成本在 1432440 欧元(DEGAM)至 2386186 欧元(DGfN/DGIM)之间。在 eGFR<60ml/min 的 190 名患者中,有 15 名患者在未来 5 年内患有终末期肾病的风险超过 5%。
应用不同的转诊标准会导致不同的转诊率和成本。转诊率超过实际观察到的就诊率。需要根据可用劳动力、资源以及肾脏病服务的过度和不足利用情况来评估标准。